Study of Stapokibart Injection in Adolescent Subjects With Seasonal Allergic Rhinitis (SAR)
Clinical trial NCT07617324 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07617324
- Sponsor
- Chengdu Kangnuoxing Biopharma,Inc.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-06-01
- Primary completion
- 2026-10-01
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.